Short answer · Medically reviewed summary · Last updated: 2026-04-06
While Chronic Obstructive Pulmonary Disease (COPD) is primarily considered a multifactorial condition influenced by environmental factors like smoking, a small subset of cases is caused by a specific hereditary genetic condition known as Alpha-1 Antitrypsin Deficiency (AATD). Understanding the Genetic Component Most cases of COPD develop through a combination of complex interactions between genetic predisposition and environmental exposures over a lifetime. However, in cases of hereditary COPD, the cause is often a mutation in the SERPINA1 gene.
3 people with COPD have shared their first-person experience on this question at DiseaseMaps.
While Chronic Obstructive Pulmonary Disease (COPD) is primarily considered a multifactorial condition influenced by environmental factors like smoking, a small subset of cases is caused by a specific hereditary genetic condition known as Alpha-1 Antitrypsin Deficiency (AATD).
Most cases of COPD develop through a combination of complex interactions between genetic predisposition and environmental exposures over a lifetime. However, in cases of hereditary COPD, the cause is often a mutation in the SERPINA1 gene. This gene is responsible for producing the alpha-1 antitrypsin protein, which protects the lungs from damage. If you inherit two non-functional copies of this gene, you are at a significantly higher risk of developing COPD, even without a history of smoking.
The inheritance pattern for Alpha-1 Antitrypsin Deficiency is codominant, meaning that if both parents are carriers, there is a 25% chance for each child to inherit two altered genes, which predisposes them to severe lung and liver issues. De novo (spontaneous) mutations are not the primary driver of this condition; rather, the risk is inherited through family lines. Because COPD risk is often multifactorial, it is difficult to provide a single percentage of risk for children of an affected parent without first determining if the parent has the specific SERPINA1 mutation.
Genetic testing for AATD is recommended for individuals diagnosed with COPD at a young age (under 45), those with a family history of emphysema, or those who develop the disease despite having no history of smoking. Genetic counseling is highly recommended for families planning a pregnancy to discuss carrier status and the potential risks for future children. While prenatal diagnosis is technically possible, it is rarely performed for this condition. A genetic counselor can help interpret your results and provide a clearer picture of what your specific genetic profile means for your health and your family’s future.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.